Literature DB >> 31595866

Congenital Chagas Disease in the Ecuadorian Amazon: Maternal Screening at Delivery and Evaluation of Risk Factors Associated with Vector Exposure.

Marion Restrepo Zambrano1,2, Faustine Rouset1,2, Otita F Carrasco3, Diana Echeverría Murillo4, Jaime A Costales1, Simone Frédérique Brenière5,1.   

Abstract

Congenital infection with Trypanosoma cruzi remains a major route for Chagas disease transmission in endemic and non-endemic regions. We evaluated an intervention strategy aimed to detect congenital Chagas disease cases at a major hospital in the Ecuadorian Amazon via cord blood analysis at the time of delivery. All women giving birth at the hospital during the study period (191) were invited to participate. Among them, two (1.0%) did not adjust to the inclusion criteria and four (2.1%) declined to participate in the study, showing the intervention had good acceptability among the mothers. It was possible to obtain cord blood samples during 146 of the deliveries, and only one woman was found to be seropositive, without evidence of transmission to the newborn at delivery or 8 months later. In addition, sociodemographic and economic characterization of the study population revealed that few women had previous knowledge about Chagas disease (16.1%) whereas more than half (62.5%) recognized the vector. Recognizing the vector and having seen it indoors were associated with women from rural families, involved in agriculture, and hunting in the forest. Interestingly, most women (87.3%) reported having easy access to Ecuador's national health system, suggesting serological screening during prenatal visits would be of value in this province. With a proper prenatal screening system in place, cord blood screening would allow for timely detection of T. cruzi infection in newborns from both seropositive women and the minority (2.1%) of women who do not comply with prenatal care visits.

Entities:  

Mesh:

Year:  2019        PMID: 31595866      PMCID: PMC6896853          DOI: 10.4269/ajtmh.19-0340

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  27 in total

1.  [Knowledge about Chagas' disease and risk factors in Argentina communities with different epidemiological trends].

Authors:  M Sanmartino; L Crocco
Journal:  Rev Panam Salud Publica       Date:  2000-03

2.  A national survey to determine prevalence of Trypanosoma cruzi infection among pregnant women in Ecuador.

Authors:  Jaime A Costales; Amaya Sánchez-Gómez; Luis C Silva-Aycaguer; William Cevallos; Susana Tamayo; César A Yumiseva; Jerry O Jacobson; Luiggi Martini; Caty A Carrera; Mario J Grijalva
Journal:  Am J Trop Med Hyg       Date:  2015-02-09       Impact factor: 2.345

3.  Adverse events after the use of benznidazole in infants and children with Chagas disease.

Authors:  Jaime Altcheh; Guillermo Moscatelli; Samanta Moroni; Facundo Garcia-Bournissen; Hector Freilij
Journal:  Pediatrics       Date:  2010-12-20       Impact factor: 7.124

4.  Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.

Authors:  Julián Ernesto Nicolás Gulin; Margarita Bisio; Daniela Marisa Rocco; Jaime Altcheh; María Elisa Solana; Facundo García-Bournissen
Journal:  Exp Parasitol       Date:  2018-02-13       Impact factor: 2.011

5.  Economic evaluation of Chagas disease screening of pregnant Latin American women and of their infants in a non endemic area.

Authors:  Elisa Sicuri; José Muñoz; Maria Jesús Pinazo; Elizabeth Posada; Joan Sanchez; Pedro L Alonso; Joaquim Gascon
Journal:  Acta Trop       Date:  2011-03-15       Impact factor: 3.112

6.  Early diagnosis of congenital Trypanosoma cruzi infection using PCR, hemoculture, and capillary concentration, as compared with delayed serology.

Authors:  María Celia Mora; Olga Sanchez Negrette; Diego Marco; Alejandra Barrio; Mirella Ciaccio; María Asunción Segura; Miguel A Basombrío
Journal:  J Parasitol       Date:  2005-12       Impact factor: 1.276

7.  Risk factors and consequences of congenital Chagas disease in Yacuiba, south Bolivia.

Authors:  N A Salas; M Cot; D Schneider; B Mendoza; J A Santalla; J Postigo; J P Chippaux; L Brutus
Journal:  Trop Med Int Health       Date:  2007-12       Impact factor: 2.622

8.  Seroprevalence and risk factors for Trypanosoma cruzi infection in the Amazon region of Ecuador.

Authors:  Mario J Grijalva; Luis Escalante; Rodrigo A Paredes; Jaime A Costales; Alberto Padilla; Edwin C Rowland; H Marcelo Aguilar; Jose Racines
Journal:  Am J Trop Med Hyg       Date:  2003-10       Impact factor: 2.345

9.  Chagas Disease Has Not Been Controlled in Ecuador.

Authors:  Eric Dumonteil; Claudia Herrera; Luiggi Martini; Mario J Grijalva; Angel G Guevara; Jaime A Costales; H Marcelo Aguilar; S Frédérique Brenière; Etienne Waleckx
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

10.  Congenital Chagas Disease in the United States: Cost Savings through Maternal Screening.

Authors:  Eileen Stillwaggon; Victoria Perez-Zetune; Stephanie R Bialek; Susan P Montgomery
Journal:  Am J Trop Med Hyg       Date:  2018-04-26       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.